<DOC>
	<DOCNO>NCT00721526</DOCNO>
	<brief_summary>The propose design single-group open-label trial . Qualified consent participant active alcohol dependence primary secondary anxiety disorder receive monitor disulfiram lorazepam , context structure Medication Management ( MM ) model . In week 9-15 lorazepam taper , disulfiram stop end week 16 . Participants achieve 4 week abstinence meet criterion primary anxiety disorder mood disorder may receive ancillary medication consist FDA-approved non-benzodiazepine treatment , specific option disorder describe protocol . Participants require continue treatment refer clinical treatment community week 16 , bridge prescription anxiolytic/antidepressant medication may provide . A final follow-up assessment occur week 28 . The primary outcome Percent Days Abstinent ( PDA ) retention treatment . Secondary alcohol outcome consequence , drink per drinking day , remission status , time first heavy drinking day . Anxiety outcomes Hamilton Anxiety Scale score anxiety disorder diagnosis .</brief_summary>
	<brief_title>Disulfiram Combined With Lorazepam Alcohol Dependence Anxiety Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Lorazepam</mesh_term>
	<mesh_term>Disulfiram</mesh_term>
	<criteria>Males female age 18 alcohol dependence . Able provide voluntary inform consent . At least 4 heavy drinking day past 30 day . Primary secondary anxiety disorder , include diagnosis generalize anxiety disorder , panic disorder , social phobia , PTSD , obsessivecompulsive disorder , alcoholinduced anxiety disorder , anxiety disorder otherwise specify , ascertain SCID . Goal abstinence . 2 day abstinence time study entry ( drink yesterday today ) . Willing come clinic 3x/week . If female childbearing potential , willing use approve method contraception . Moderate severe withdrawal ( CIWAA great 15 ) , history withdrawal seizures delirium tremens . Medical condition ( seizure disorder , sleep apnea , significantly impair liver function , chronic acute nephritis , symptomatic coronary artery disease , acute narrowangle glaucoma ) . Urine drug screen positive opioids barbiturate . Hypersensitivity thiuram derivative . Pregnancy . Laboratory abnormality ( LFT great 3 time normal , ECG evidence ischemia , UA suggestive nephritis , serious abnormality CBC ) . Need take excluded medication ( e.g . amprenavir oral solution , diazoxide oral suspension , isoniazid , lopinavir/ritonavir oral solution , metronidazole , omeprazole , phenytoin , ritonavir , tinidazole , tipranavir , warfarin , azelastine , sodium oxybate ) . Psychiatric condition ( schizophrenia , schizoaffective disorder , bipolar disorder ; opioid dependence , benzodiazepine sedative hypnotic dependence ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>alcohol dependence</keyword>
	<keyword>alcoholism</keyword>
	<keyword>anxiety disorder</keyword>
	<keyword>pharmacotherapy</keyword>
	<keyword>disulfiram</keyword>
	<keyword>lorazepam</keyword>
</DOC>